[Efficacy and Survival Analysis of Chidamide Combined with DICE Regimen in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma].
The chidamide combined with DICE regimen is effective in the treatment of R/R DLBCL, and hematological adverse events should be closely monitored.
Authors
- Yun Feng (ORCID: https://orcid.org/0000-0002-9208-8243)
- Lihong Liu (ORCID: https://orcid.org/0009-0001-3308-1332)
- Wei Liu (ORCID: https://orcid.org/0000-0001-8920-1172)
- Weijing Li (ORCID: https://orcid.org/0000-0001-7868-1342)
- Lili Wu (ORCID: https://orcid.org/0000-0001-8601-0637)
- Shaoning Yin
- Can He
- Li Shi (ORCID: https://orcid.org/0000-0002-3116-8880)
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.19746/j.cnki.issn.1009-2137.2025.02.010
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article